Astera Labs, Inc. $ALAB Shares Purchased by Swiss National Bank

Key Points

• Swiss National Bank boosted its position in Astera Labs by 4.0% to 257,600 shares (about 0.15% of the company) worth $50.4 million, and institutional investors collectively own 60.47% of the stock with Vanguard holding 13.74 million shares ($2.69B).
• Insider selling was significant: the CEO and CFO sold 94,971 and 12,001 shares respectively on Feb. 17, and insiders sold 224,292 shares (~$27.68M) in the last quarter, leaving insiders with 12.5% ownership.
• Fundamentals beat expectations: the company reported $0.58 EPS vs. $0.51 expected and revenue of $270.6M (up 91.8% YoY), set Q1 2026 EPS guidance of $0.530–$0.540, and carries a consensus analyst rating of "Moderate Buy" with a $195.89 target.

Swiss National Bank boosted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 4.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 257,600 shares of the company's stock after purchasing an additional 9,800 shares during the period. Swiss National Bank owned approximately 0.15% of Astera Labs worth $50,438,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of Astera Labs by 14.1% during the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company's stock valued at $2,690,907,000 after buying an additional 1,693,918 shares during the period. State Street Corp raised its position in Astera Labs by 39.3% in the second quarter. State Street Corp now owns 2,143,459 shares of the company's stock valued at $193,812,000 after purchasing an additional 604,363 shares during the period. 1832 Asset Management L.P. grew its holdings in shares of Astera Labs by 151.4% during the 2nd quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company's stock worth $139,563,000 after purchasing an additional 929,600 shares during the period. Massachusetts Financial Services Co. MA increased its position in shares of Astera Labs by 46.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company's stock worth $295,203,000 after purchasing an additional 479,360 shares during the last quarter. Finally, Geode Capital Management LLC raised its holdings in Astera Labs by 36.2% in the 2nd quarter. Geode Capital Management LLC now owns 1,244,978 shares of the company's stock valued at $112,562,000 after buying an additional 330,841 shares during the period. Hedge funds and other institutional investors own 60.47% of the company's stock.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CFO Michael Truett Tate sold 12,001 shares of Astera Labs stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $1,485,843.81. Following the completion of the sale, the chief financial officer directly owned 192,083 shares of the company's stock, valued at $23,781,796.23. The trade was a 5.88% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Jitendra Mohan sold 94,971 shares of the firm's stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the sale, the chief executive officer directly owned 1,452,739 shares in the company, valued at $179,863,615.59. This trade represents a 6.14% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 224,292 shares of company stock worth $27,676,069. 12.50% of the stock is currently owned by company insiders.

Astera Labs Price Performance

ALAB stock opened at $119.90 on Friday. The business's 50-day moving average is $149.08 and its two-hundred day moving average is $168.55. The firm has a market capitalization of $20.41 billion, a P/E ratio of 98.28, a P/E/G ratio of 2.45 and a beta of 1.74. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts' consensus estimates of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. During the same period in the prior year, the firm earned $0.37 earnings per share. The business's quarterly revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have weighed in on ALAB. Barclays set a $165.00 target price on shares of Astera Labs in a research note on Thursday, January 15th. Citigroup decreased their price objective on shares of Astera Labs from $275.00 to $250.00 and set a "buy" rating on the stock in a report on Wednesday, February 11th. Royal Bank Of Canada initiated coverage on shares of Astera Labs in a report on Wednesday, January 14th. They issued an "outperform" rating and a $225.00 target price for the company. BNP Paribas Exane assumed coverage on Astera Labs in a research report on Thursday, November 20th. They issued an "outperform" rating on the stock. Finally, Morgan Stanley restated an "overweight" rating and set a $210.00 price target on shares of Astera Labs in a research report on Wednesday, December 3rd. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Astera Labs currently has an average rating of "Moderate Buy" and a consensus price target of $195.89.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.